AstraZeneca
A Scientist, Viral Vector Process Development plays a critical role in accelerating AstraZeneca’s Cell Therapy modalities portfolio by designing, executing, and optimizing upstream Lentiviral Vector processes for suspension cell culture.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
10% below the average for this role
Sr. Scientist - Viral Vector Expression (Biotechnology Discovery Research)
Eli Lilly and Company
Senior Scientist, Viral Vector Process Development, Upstream
American Association of Physicists in Medicine
Scientist
Asimov
Upstream Manufacturing Manager
Genezen
Upstream Principal Scientist, Vector Biology
Legend Biotech
Scientist
Legend Biotech